| VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2 D Zhao, C Pan, J Sun, C Gilbert, K Drews-Elger, DJ Azzam, M Picon-Ruiz, ... Oncogene 34 (24), 3107-3119, 2015 | 273 | 2015 |
| p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies SA Wander, D Zhao, JM Slingerland Clinical cancer research 17 (1), 12-18, 2011 | 208 | 2011 |
| Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression Cancer Research, 2016 | 175 | 2016 |
| Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation D Zhao, AH Besser, SA Wander, J Sun, W Zhou, B Wang, T Ince, ... Oncogene 34 (43), 5447-5459, 2015 | 139 | 2015 |
| Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis T Kwak, K Drews-Elger, A Ergonul, PC Miller, A Braley, GH Hwang, ... Oncogene 36 (11), 1559-1572, 2017 | 137 | 2017 |
| Molecularly targeted therapies for p53-mutant cancers D Zhao, WM Tahaney, A Mazumdar, MI Savage, PH Brown Cellular and molecular life sciences 74, 4171-4187, 2017 | 85 | 2017 |
| Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ‐secretase inhibitor drug responses DJ Azzam, D Zhao, J Sun, AJ Minn, P Ranganathan, K Drews‐Elger, ... EMBO molecular medicine 5 (10), 1502-1522, 2013 | 84 | 2013 |
| The susceptibility to vitiligo is associated with NF‐E2‐related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population CP Guan, MN Zhou, AE Xu, KF Kang, JF Liu, XD Wei, YW Li, DK Zhao, ... Experimental dermatology 17 (12), 1059-1062, 2008 | 74 | 2008 |
| Dual Src and MEK inhibition decreases ovarian cancer growth and targets tumor initiating stem-like cells F Simpkins, K Jang, H Yoon, KE Hew, M Kim, DJ Azzam, J Sun, D Zhao, ... Clinical cancer research 24 (19), 4874-4886, 2018 | 67 | 2018 |
| Death-associated protein kinase 1 promotes growth of p53-mutant cancers J Zhao, D Zhao, GM Poage, A Mazumdar, Y Zhang, JL Hill, ZC Hartman, ... The Journal of clinical investigation 125 (7), 2707-2720, 2015 | 64 | 2015 |
| PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy SA Wander, D Zhao, AH Besser, F Hong, J Wei, TA Ince, C Milikowski, ... Breast cancer research and treatment 138, 369-381, 2013 | 53 | 2013 |
| SOX9 is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis PHB Yanxia Ma, Jonathan Shepherd, Dekuang Zhao, Lakshmi Reddy Bollu, William ... Mol Cancer Res, 2020 | 51 | 2020 |
| Direct and immune-mediated cytotoxicity of interleukin-21 contributes to anti-tumor effects in mantle cell lymphoma. LIS Bhatt S, Matthews J, Parvin S, Sarosiek KA, Zhao D, Jiang X, Isik E, Letai A Blood, 2015 | 38* | 2015 |
| p27 transcriptionally coregulates cJun to drive programs of tumor progression JMS Hyunho Yoon, Minsoon Kim, Kibeom Jang, Miyoung Shin, Alexandra Besser ... Proceedings of the National Academy of Sciences of the United States of America, 2019 | 37* | 2019 |
| Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1 LR Bollu, J Shepherd, D Zhao, Y Ma, W Tahaney, C Speers, A Mazumdar, ... NPJ Breast cancer 6 (1), 2, 2020 | 20 | 2020 |
| EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma X Hong, Y Liu, G Hu, D Zhao, J Shen, F Shen, X Cao, Q Wang Cancer science 100 (5), 961-969, 2009 | 19 | 2009 |
| Melagenine modulates proliferation and differentiation of melanoblasts D Zhao, Y Li, P Wang, M Zhou, C Guan, X Wei, Y Wan, A Xu International journal of molecular medicine 22 (2), 193-197, 2008 | 16 | 2008 |
| Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect G Hu, Y Liu, H Li, D Zhao, L Yang, J Shen, X Hong, X Cao, Q Wang Cellular & Molecular Immunology 7 (4), 296-305, 2010 | 12 | 2010 |
| Abstract P1-08-04: SOX9 is a critical regulator of triple-negative breast cancer cell growth and invasion Y Ma, J Shepherd, A Mazumdar, D Zhao, L Bollu, J Hill, Y Zhang, P Brown Cancer Research 77 (4_Supplement), P1-08-04-P1-08-04, 2017 | 4 | 2017 |
| Induction of potent anti-tumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation J Zhang, Q Wang, D Zhao, X Cao Cytotherapy 9 (4), 386-396, 2007 | 4 | 2007 |
Chad CreightonProfessor of Medicine, Baylor College of MedicineVerified email at bcm.edu
